Forbion Capital Partners

Forbion Capital Partners invests in Life Sciences and Biomedical Technology companies developing worldclass drugs and technologies, with a clear focus on product development..

Suggest edits

Type

B2b

Founded

2007

Follow us

Companies in the same industry

Built with ❤︎ by Datalicious ©2021
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 24

Portfolio

Portfolio Tracker

Add info

Add round

03 Jun 2020

$62,500,000

Venture capital (Series A)

Forbion Capital Partners, Sectoral Asset Management, Morningside Venture Investments, +1

Prilenia Therapeutics Raises $62.5M in Series A Funding

FinSMEs

18 Feb 2020

€25,000,000

Venture capital (Series A)

BioMedPartners, Forbion Capital Partners, BioGeneration Ventures

Azafaros Closes €25M Series A Financing

FinSMEs

03 Apr 2019

$50,000,000

Venture capital (Series A)

MPM Capital, Forbion Capital Partners

29 Aug 2018

£25,000,000

Venture capital (Series C)

Fountain Healthcare Partners, OrbiMed, Forbion Capital Partners, +2

KaNDy Therapeutics Raises £25M in Series C Financing

FinSMEs

12 Dec 2017

€25,000,000

Venture capital (Series A)

New Science Ventures, Forbion Capital Partners, BioGeneration Ventures, +1

11 Dec 2017

$59,600,000

Venture capital (Series C)

Sofinnova Partners, BioMedPartners, Forbion Capital Partners, +6

| Hookipa Biotech scores $59.6 mln Series C

PE HUB

01 Aug 2017

$55,000,000

Venture capital (Series C)

Fonds de solidarité FTQ, Domain Associates, BDC Capital, +5

Milestone Pharmaceuticals Closes $55 Million Series C Financing

prnewswire

24 Jul 2017

$30,000,000

Venture capital (Series C)

CD-Venture, Arcus Ventures, NGN Capital, +4

citybizlist : Exosome Diagnostics Raises $30M Series C

citybizlist

07 Feb 2017

€29,000,000

Venture capital (Series B)

Sunstone Capital, Seroba Kernel, Forbion Capital Partners, +2

Prexton Therapeutics, participated by Ysios Capital, Series B financing round raises € 29 millions to advance its novel Parkinson’s therapeutic.es

capital-riesgo

05 Jan 2017

£23,000,000

Venture capital (Series B)

Fountain Healthcare Partners, OrbiMed, Novo A/S, +2

NeRRE Therapeutics picks up Series B funds

PE Hub

06 Sep 2016

€15,000,000

Venture capital (Series A)

High-Tech Gruenderfonds, Sunstone Capital, MP Healthcare Venture Management, +3

Rigontec Raises €15M in Third Closing of Series A Funding

FinSMEs

15 Jun 2016

€22,000,000

Venture capital (Series B)

EMBL Ventures, Forbion Capital Partners, Edmond de Rothschild Investment Partners, +2

Allecra Therapeutics Announces €22 Million Series B Financing

prnewswire

16 Feb 2016

$15,000,000

Venture capital (Series B)

New Science Ventures, Third Point Ventures, Forbion Capital Partners

Akarna Therapeutics Closes $15M Series B Financing

FinSMEs

07 Jan 2016

$60,000,000

Venture capital (Series B)

Tiger Management, Qiagen, Arcus Ventures, +4

Exosome Diagnostics Completes $60 Million Series B Financing

businesswire

02 Sep 2015

$17,600,000

Venture capital (Series B)

Tiger Management, CD-Venture, Arcus Ventures, +2

Exosome Diagnostics Raises $17.6 Million in Second Round Series B Financing

BioPortfolio

11 Mar 2014

$27,000,000

Venture capital (Series B)

b-to-v Partners AG, Qiagen, Arcus Ventures, +2

Exosome Diagnostics raises USD 27m in Series B Financing Partners AG

b-to-v

25 Jul 2012

$60,000,000

Venture capital (Series D)

RA Capital Management, ARCH Venture Partners, Third Rock Ventures, +4

20 Apr 2011

$30,000,000

Venture capital

Easton Capital, ARCH Venture Partners, Third Rock Ventures, +2

04 Feb 2011

$48,268,413

Venture capital (Series B)

Advent Venture Partners, Auriga Partners, Crédit Agricole Private Equity, +5

04 Jan 2011

$33,000,000

Venture capital

Adams Street Partners, Endeavour Vision, Leader Ventures, +5

Index

By TNW